Drugs / iCo-007
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00886808 | Feb 2008 → May 2010 | diabetic macular edema | iCo Therapeutics Inc. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01565148 | Feb 2012 → Feb 2014 | diabetic macular edema | Johns Hopkins University | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iCo-007 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00886808 ↗ |
| Route | Intravitreal | “iCo-007 Intravitreal Injection” NCT00886808 ↗ |